US Congress Senate Bill 2051 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on June 28 2019 - 25% progression, died in committee
Action: 2019-06-28 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

Strengthening Average Sales Price Reporting Act of 2019

Sen. Robert Menendez [D-NJ]

Sen. Todd Young [R-IN]

Date	Chamber	Action
2019-06-28	Senate	Read twice and referred to the Committee on Finance.

HB2087 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB2113 (Related) 2020-12-24 - Placed on the Union Calendar, Calendar No. 571.
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
HB1570 (Related) 2020-12-10 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/2051/all-info
Text	https://www.congress.gov/116/bills/s2051/BILLS-116s2051is.pdf